Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Industry wary of NIH consultancy moratorium

Time is needed to assess how appropriate is the NIH proposal.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

Authors

Related links

Related links

Related links in Nature Research

Conflicts at the NIH (cont.)

Panel slated for leniency over study of NIH consulting roles

NIH urged to rewrite rules on consultancies

Related external links

House Subcommittee on Oversight and Investigations

Biotechnology Industry Organization

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fox, J. Industry wary of NIH consultancy moratorium. Nat Biotechnol 22, 1331–1332 (2004). https://doi.org/10.1038/nbt1104-1331

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1104-1331

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing